Paper39656458
Chlorthalidone vs Hydrochlorothiazide and Kidney Outcomes in Patients With Hypertension: A Secondary Analysis of a Randomized Clinical Trial.
Ishani A and 8 others. JAMA Netw Open, 2024. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Chlorthalidone vs Hydrochlorothiazide and Kidney Outcomes in Patients With Hypertension: A Secondary Analysis of a Randomized Clinical Trial. Papers, record 39656458. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39656458
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chlorthalidone | Major topic |
| Hydrochlorothiazide | Major topic |
| Hypertension | Major topic |
| Renal Insufficiency, Chronic | Major topic |
| Antihypertensive Agents | Major topic |
| Humans | |
| Male | |
| Female | |
| Aged | |
| Glomerular Filtration Rate | |
| Disease Progression | |
| Diuretics | |
| Treatment Outcome |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02185417 | Diuretic Comparison Project | Derived from the trial | Yes |
Source ClinicalTrials.gov
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32065600 | Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension. | JAMA Intern Med | 2020 | https://conductscience.org/library/papers/32065600 | PubMed |
| 2 | 20332509 | CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. | BMJ | 2010 | https://conductscience.org/library/papers/20332509 | PubMed |
| 3 | 22490878 | Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR. | Clin J Am Soc Nephrol | 2012 | https://conductscience.org/library/papers/22490878 | PubMed |
| 4 | 37345492 | 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). | J Hypertens | 2023 | https://conductscience.org/library/papers/37345492 | PubMed |
| 5 | 2046107 | Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. | JAMA | 1991 | https://conductscience.org/library/papers/2046107 | PubMed |
| 6 | 12479763 | Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). | JAMA | 2002 | https://conductscience.org/library/papers/12479763 | PubMed |
| 7 | 36822739 | US Renal Data System 2022 Annual Data Report: Epidemiology of Kidney Disease in the United States. | Am J Kidney Dis | 2023 | https://conductscience.org/library/papers/36822739 | PubMed |
| 8 | 36516076 | Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events. | N Engl J Med | 2022 | https://conductscience.org/library/papers/36516076 | PubMed |
| 9 | 35390512 | Design of a pragmatic clinical trial embedded in the Electronic Health Record: The VA's Diuretic Comparison Project. | Contemp Clin Trials | 2022 | https://conductscience.org/library/papers/35390512 | PubMed |
| 10 | 23154648 | Associations of proteinuria, fluid volume imbalance, and body mass index with circadian ambulatory blood pressure in chronic kidney disease patients. | Kidney Blood Press Res | 2012 | https://conductscience.org/library/papers/23154648 | PubMed |
| 11 | 28271257 | Outcomes of diuretic use in pre-dialysis CKD patients with moderate renal deterioration attending tertiary care referral center. | Clin Exp Nephrol | 2017 | https://conductscience.org/library/papers/28271257 | PubMed |
| 12 | 15615808 | A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension. | Nephrol Dial Transplant | 2005 | https://conductscience.org/library/papers/15615808 | PubMed |
| 13 | 15851647 | Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). | Arch Intern Med | 2005 | https://conductscience.org/library/papers/15851647 | PubMed |
| 14 | 34524440 | Comparison of Clinical Outcomes and Safety Associated With Chlorthalidone vs Hydrochlorothiazide in Older Adults With Varying Levels of Kidney Function. | JAMA Netw Open | 2021 | https://conductscience.org/library/papers/34524440 | PubMed |
| 15 | 35105612 | Loop and thiazide diuretic use and risk of chronic kidney disease progression: a multicentre observational cohort study. | BMJ Open | 2022 | https://conductscience.org/library/papers/35105612 | PubMed |
| 16 | 24092942 | Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials. | BMJ | 2013 | https://conductscience.org/library/papers/24092942 | PubMed |
| 17 | 23552325 | Chlorthalidone versus hydrochlorothiazide for the treatment of hypertension in older adults: a population-based cohort study. | Ann Intern Med | 2013 | https://conductscience.org/library/papers/23552325 | PubMed |
| 18 | 29133356 | 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. | Hypertension | 2018 | https://conductscience.org/library/papers/29133356 | PubMed |
| 19 | 37244366 | Telephone informed consent in a pragmatic point-of-care clinical trial embedded in primary care. | Contemp Clin Trials | 2023 | https://conductscience.org/library/papers/37244366 | PubMed |
| 20 | 33637192 | KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. | Kidney Int | 2021 | https://conductscience.org/library/papers/33637192 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41363010 | Aprocitentan in Patients With Chronic Kidney Disease and Resistant Hypertension. | Hypertension | 2026 | https://conductscience.org/library/papers/41363010 | PubMed |
| 41234923 | Management of hypertension in chronic kidney disease: current perspectives and therapeutic strategies. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/41234923 | PubMed |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| CHLORTHALIDONE | CHEMBL1055 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1055 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39656458
GET https://conductscience.org/api/papers/v1/39656458/references?page=2